Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01442493 · ClinicalTrials.gov registry record · NA

Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment

A NA study of Opiate Dependence, sponsored by Friends Research Institute.

Completed
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT01442493 is a NA study of Opiate Dependence that has completed, run by Friends Research Institute. The registered enrollment target is 300 participants, below the 587-participant average among 15 other Opiate Dependence trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01442493, a NA study of Opiate Dependence, has completed, sponsored by Friends Research Institute.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.

Conditions Studied

Interventions

  • OTHER Patient-Centered Methadone Treatment
  • OTHER Methadone Treatment as usual

Study Locations (2)

Maryland

  • Institutes for Behavior Resources REACH - Baltimore
  • University of Maryland Drug Treatment Center - Baltimore

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2011-09
Est. Completion 2015-08
Phase NA

Sponsor

Friends Research Institute

41 total trials

What the Registry Record Tells You About NCT01442493

The ClinicalTrials.gov registry entry for NCT01442493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 587-participant average among 15 other Opiate Dependence trials with a reported enrollment target (49% lower). The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opiate Dependence appearing as the primary indexed condition, and to 2 interventions - of which Patient-Centered Methadone Treatment is the first listed.

NCT01442493 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01442493 about?

NCT01442493 is a clinical study titled "Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment". The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.

What is the current status of trial NCT01442493?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2011-09. Estimated completion is 2015-08.

What conditions does trial NCT01442493 study?

This clinical trial studies the following conditions: Opiate Dependence.

What interventions are being tested in trial NCT01442493?

The interventions under investigation include: Patient-Centered Methadone Treatment (OTHER), Methadone Treatment as usual (OTHER).

Who is sponsoring clinical trial NCT01442493?

This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01442493 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opiate Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.